These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 20430978)

  • 41. Cortical Functional Connections and Fluid Intelligence in Adolescent APOE ε4 Carriers.
    Woo M; Kim Y
    Dement Geriatr Cogn Disord; 2017; 44(3-4):153-159. PubMed ID: 28848214
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Statin users without an APOE-epsilon4 allele have increased insulin resistance.
    VanFossen BT; Watson GS; Baker LD; Rhoads KW; Cholerton BA; Reger MA; Plymate SR; Schellenberg G; Craft S
    J Alzheimers Dis; 2010; 19(4):1149-53. PubMed ID: 20308781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alzheimer disease: Joining the dots between APOE ε4 and late-onset Alzheimer disease via integrative genomics.
    Kingwell K
    Nat Rev Neurol; 2013 Sep; 9(9):483. PubMed ID: 23938735
    [No Abstract]   [Full Text] [Related]  

  • 44. Longevity Gene KLOTHO and Alzheimer Disease-A Better Fate for Individuals Who Carry APOE ε4.
    Dubal DB; Yokoyama JS
    JAMA Neurol; 2020 Jul; 77(7):798-800. PubMed ID: 32282012
    [No Abstract]   [Full Text] [Related]  

  • 45. Alzheimer disease: APOE ε4 affects cognitive decline but does not block benefits of healthy lifestyle.
    Fyfe I
    Nat Rev Neurol; 2018 Mar; 14(3):125. PubMed ID: 29422646
    [No Abstract]   [Full Text] [Related]  

  • 46. APOE ε4 Association With Cognition and Alzheimer Disease Biomarkers in Down Syndrome-Implications for Clinical Trials and Treatments for All.
    Lemere CA; Head E; Holtzman DM
    JAMA Neurol; 2021 Aug; 78(8):913-915. PubMed ID: 34228117
    [No Abstract]   [Full Text] [Related]  

  • 47. The apolipoprotein-epsilon4 gene: always harmful?
    Teasdale TW
    J Neurol Neurosurg Psychiatry; 2008 Apr; 79(4):364-5. PubMed ID: 18344388
    [No Abstract]   [Full Text] [Related]  

  • 48. Imaging and rare APOE alleles: Alzheimer disease as a developmental disorder.
    Knickmeyer RC; Ross ME
    Neurology; 2016 Aug; 87(6):558-9. PubMed ID: 27412139
    [No Abstract]   [Full Text] [Related]  

  • 49. Longitudinal visual evoked potentials in Alzheimer's disease: a preliminary report.
    Swanwick GR; Rowan M; Coen RF; O'Mahony D; Lawlor BA; Walsh JB; Coakley D
    Biol Psychiatry; 1996 Mar; 39(6):455-7. PubMed ID: 8679793
    [No Abstract]   [Full Text] [Related]  

  • 50. APOE
    Fyfe I
    Nat Rev Neurol; 2020 Apr; 16(4):185. PubMed ID: 32107475
    [No Abstract]   [Full Text] [Related]  

  • 51. Alzheimer disease: Effects of the APOE ε4 allele on brain development.
    Malkki H
    Nat Rev Neurol; 2014 Jan; 10(1):4. PubMed ID: 24323049
    [No Abstract]   [Full Text] [Related]  

  • 52. Photic evoked cerebral potentials in cerebrovascular diseases; the evoked potentials in hypertensive patients with and without hemodynamic alterations in the brain stem.
    Crighel E; Stoica E; Enulescu O; Matei M
    Neurol Psychiatr (Bucur); 1986; 24(2):97-104. PubMed ID: 3738378
    [No Abstract]   [Full Text] [Related]  

  • 53. Camelford water incident.
    Altmann P; Cunningham J; Marsh F; Dhanesha U; Ballard M; Thompson J
    BMJ; 2000 Jun; 320(7248):1536. PubMed ID: 10877574
    [No Abstract]   [Full Text] [Related]  

  • 54. The role of APOE in cerebrovascular dysfunction.
    Tai LM; Thomas R; Marottoli FM; Koster KP; Kanekiyo T; Morris AW; Bu G
    Acta Neuropathol; 2016 May; 131(5):709-23. PubMed ID: 26884068
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electroencephalogram and Alzheimer's disease: clinical and research approaches.
    Tsolaki A; Kazis D; Kompatsiaris I; Kosmidou V; Tsolaki M
    Int J Alzheimers Dis; 2014; 2014():349249. PubMed ID: 24868482
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebrovascular function in aging and dementia: a systematic review of transcranial Doppler studies.
    Keage HA; Churches OF; Kohler M; Pomeroy D; Luppino R; Bartolo ML; Elliott S
    Dement Geriatr Cogn Dis Extra; 2012 Jan; 2(1):258-70. PubMed ID: 22822408
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of ApoE epsilon4 allele on visual evoked potentials and resultant flow coupling in patients with Alzheimer.
    Rosengarten B; Paulsen S; Burr O; Kaps M
    J Geriatr Psychiatry Neurol; 2010 Sep; 23(3):165-70. PubMed ID: 20430978
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.
    Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS
    J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.
    Filippini N; Rao A; Wetten S; Gibson RA; Borrie M; Guzman D; Kertesz A; Loy-English I; Williams J; Nichols T; Whitcher B; Matthews PM
    Neuroimage; 2009 Feb; 44(3):724-8. PubMed ID: 19013250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
    Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.